AEMD

Aethlon Medical, Inc.

$5.55

1.09%
SectorHealthcareIndustryMedical DevicesCountryUnited States

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation, and other disease states. The company was founded in 1984 and is based in San Diego, California.

Source: Yahoo Finance
AI summary

Price & performance

1M+260.1%
3M+53.7%
YTD-63.5%
1Y-81.3%
52-week range—
Beta1.38
Full chart and returns against a benchmark

Q-Score

25/ 100

Quality against peers; 50 is the peer median.

Growth18
Risk21
Performance38
Valuation33
Profitability36
Leverage42
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2026

Revenue—
Net income-$7.2M
Net margin—
Historical fundamentals

Red flags in filings

1active red flag
Going-concern doubtJun 10, 2026
Filings, findings and the timeline

Revenue exposure

0%of revenue from outside the US
United States100%
Regions, segments, customers and suppliers

Valuation

AEMDIndustryP/E—29.61P/S—3.49EV/EBITDA—18.38P/B1.713.39PEG——
Dividend yield0.00%
Every valuation metric

Earnings

Nov 11next report
EPS estimate$-2.90
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate